Other Pharmacology Flashcards
Mechanism of: NON-NITROGEN BISPHOSPHONATES
osteoclast APOPTOSIS (ATP competitive inhibition)
Mechanism of: NITROGEN BISPHOSPHONATES
osteoclast DYSFUNCTION (farnesyl pyrophosphate synthase inhibition in HMG-CoA reductase pathway)
Mechanism of: CORTICOSTEROIDS
PHOSPHOLIPASE A2 inhibition
Mechanism of: DENOSUMAB
RANKL inhibition
Mechanism of: TERIPARATIDE
parathyroid hormone, anabolic – activates osteoblasts and osteoclasts (blast > clast) – should only be used for 2 years max 2/2 risk of osteosarcoma– (off label use to treat fx non-unions reported)
Mechanism of: ABATACEPT
MHC receptor antagonist
– recombinant fusion protein that targets MHC-R on antigen presenting cells to block T-cell activation
Mechanism of: ANAKINRA
IL-1 receptor antagonist
– blocking IL-1’s pro-inflammatory signaling pathway
Which DMARDs are antibodies to TNF-alpha?
INFLIXimab
ADALIMumab
CANAKINumab